Valuation: STCube, Inc.

Market Cap 507B 335M 294M 272M 251M 476M 32.12B 485M 3.27B 1.27B 15.72B 1.26B 1.23B 54.57B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 449B 297M 261M 241M 223M 422M 28.48B 430M 2.9B 1.13B 13.94B 1.12B 1.09B 48.38B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24/10/24 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
26/08/24 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
28/03/24 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
06/09/23 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
21/03/23 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
08/03/22 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
28/12/20 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
18/12/20 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
12/07/20 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
02/03/20 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
25/05/18 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
25/04/18 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
19/09/16 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day+0.54%
1 week-14.74%
Current month-13.66%
1 month-23.64%
3 months-52.03%
6 months-9.47%
Current year-9.02%
1 week 7,320
Extreme 7320
8,540
1 month 7,320
Extreme 7320
11,750
Current year 6,950
Extreme 6950
22,500
1 year 6,810
Extreme 6810
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 29/03/2013
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 01/03/2014
Director TitleAgeSince
Director/Board Member 61 01/03/2013
Director/Board Member 54 01/03/2013
Director/Board Member 62 01/03/2014
Date Insider Type Main position Quantity % Market Cap.
03/12/24Buy

Chief Technology Officer

164,014 0.2515%
03/12/24Buy

Chief Financial Officer

47,582 0.0730%
03/12/24
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%-14.74%-3.74%-48.90% 334M
+1.20%-7.39%+33.26%+14.60% 111B
+8.21%-4.49%+391.11%+949.33% 51.94B
+8.75%+6.18%+181.17%+420.64% 48.86B
+2.55%-8.59%+106.98%+212.57% 38.49B
+2.00%-2.49%+125.61%+96.52% 29.37B
+0.35%-1.73%+23.27%+54.75% 29.63B
+1.75%-1.81%-17.61%-35.59% 21.78B
+2.22%-8.31%+13.25%+68.21% 18.05B
+3.59%-12.36%+73.72%+136.01% 16.88B
Average +3.02%-7.57%+92.70%+186.81% 36.67B
Weighted average by Cap. +3.47%-7.63%+115.80%+236.86%

Financials

2024 2025
Net sales 11.3B 7.48M 6.56M 6.06M 5.6M 10.61M 716M 10.82M 72.8M 28.29M 350M 28.08M 27.47M 1.22B 6.98B 4.62M 4.05M 3.74M 3.46M 6.56M 443M 6.69M 45M 17.49M 217M 17.36M 16.98M 752M
Net income -21.44B -14.19M -12.45M -11.49M -10.62M -20.13M -1.36B -20.53M -138M -53.67M -665M -53.29M -52.12M -2.31B -21.8B -14.43M -12.66M -11.69M -10.8M -20.47M -1.38B -20.88M -140M -54.58M -676M -54.19M -53M -2.35B
Net Debt -79.55B -52.66M -46.19M -42.64M -39.4M -74.69M -5.04B -76.18M -513M -199M -2.47B -198M -193M -8.57B -57.42B -38.01M -33.34M -30.78M -28.44M -53.91M -3.64B -54.99M -370M -144M -1.78B -143M -140M -6.18B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
09/07/26 7,460.00 +0.54% 190,283
08/07/26 ₩7,420.00 -6.31% 244,834
07/07/26 ₩7,920.00 -2.10% 201,443
06/07/26 ₩8,090.00 -0.12% 206,421
03/07/26 ₩8,100.00 -2.17% 234,216
  1. Stock Market
  2. Stocks
  3. A052020 Stock